NASDAQ:TOI • US68236X1000
Past quarterly earnings results for ONCOLOGY INSTITUTE INC/THE (TOI), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | -0.14 | -0.11 | -22.31% | 22.22% | 136.564M | 123.86M | 10.26% | 36.70% |
| Q2 2025 | -0.15 | -0.13 | -14.24% | 11.76% | 119.802M | 115.75M | 3.50% | 21.53% |
| Q1 2025 | -0.17 | - | 22.73% | 104.41M | - | 10.29% | ||
| Q4 2024 | -0.07 | - | 66.33% | 100.267M | 110.24M | -9.05% | 16.88% | |
| Q3 2024 | -0.18 | -0.06 | -197.03% | 5.26% | 99.9M | 108.62M | -8.03% | 21.78% |
| Q2 2024 | -0.17 | -0.10 | -68.32% | 10.53% | 98.578M | 104.34M | -5.52% | 22.88% |
| Q1 2024 | -0.22 | -0.12 | -81.52% | -120.00% | 94.666M | 96.117M | -1.51% | 24.25% |
| Q4 2023 | -0.21 | -0.11 | -89.02% | 16.00% | 85.788M | 82.862M | 3.53% | 20.12% |
| Q3 2023 | -0.19 | -0.13 | -44.71% | 24.00% | 82.035M | 75.411M | 8.78% | 26.25% |
| Q2 2023 | -0.19 | -0.17 | -10.66% | - | 80.224M | 74.527M | 7.64% | 31.69% |
| Q1 2023 | -0.10 | - | - | 76.19M | - | 38.13% | ||
| Q4 2022 | -0.25 | -0.18 | -37.51% | - | 71.42M | 65.398M | 9.21% | 36.56% |
| Q3 2022 | -0.25 | -0.18 | -37.51% | - | 64.98M | 69.64M | -6.69% | 24.32% |
| Q2 2022 | - | - | 60.92M | - | 22.23% | |||
| Q1 2022 | - | - | 55.16M | - | 13.54% | |||
| Q4 2021 | - | - | 52.3M | - | 6.80% | |||
| Q3 2021 | - | - | 52.27M | - | 10.62% | |||
| Q2 2021 | - | - | 49.84M | - | - | |||
| Q1 2021 | - | - | 48.58M | - | - | |||
| Q4 2020 | - | - | 48.97M | - | - | |||
| Q3 2020 | - | - | 47.25M | - | - |
Notes
ONCOLOGY INSTITUTE INC/THE (TOI) last reported earnings on 11/13/2025.
ONCOLOGY INSTITUTE INC/THE (TOI) missed EPS estimates and beat revenue estimates in the most recent quarter.